Sydnonimines-specific dopamine reuptake inhibitors and their use in treating dopamine related disorders

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9604945
SERIAL NO

13851359

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Derivatives of Sydnonimine and its analogues, which bind selectively to dopamine transporter (DAT) proteins are useful for treating and delaying the progression of disorders and illnesses that are alleviated by inhibiting dopamine reuptake.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CALIPER LIFE SCIENCES INCHOPKINTON MA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Hao Columbia, US 1012 6150
Liu, Ming Rockville, US 547 2816
Raisinghani, Manish Jamesburg, US 4 13
Su, Qi Columbia, US 42 525

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 28, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00